Cargando…

Butyrate inhibits iILC2-mediated lung inflammation via lung-gut axis in chronic obstructive pulmonary disease (COPD)

BACKGROUND: The study investigated the effects and underlying mechanisms of intestinal flora metabolite butyrate on inflammatory ILC2 cells (iILC2s)-mediated lung inflammation in chronic obstructive pulmonary disease (COPD). METHODS: Mouse models of COPD and acute exacerbation of COPD (AECOPD) were...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Min, Li, Zhiwei, Zhang, Fengbo, Li, Zheng, Xu, Dan, Jing, Jing, Li, Fengsen, Wang, Jing, Ding, Jianbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10182695/ https://www.ncbi.nlm.nih.gov/pubmed/37173731 http://dx.doi.org/10.1186/s12890-023-02438-z

Ejemplares similares

ILC2s Induce Adaptive Th2-Type Immunity in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: Jiang, Min, et al.
Publicado: (2019)

The Heterogeneity, Origins, and Impact of Migratory iILC2 Cells in Anti-helminth Immunity
por: Miller, Mindy M., et al.
Publicado: (2020)

ILC2 Cells Promote Th2 Cell Differentiation in AECOPD Through Activated Notch-GATA3 Signaling Pathway
por: Jiang, Min, et al.
Publicado: (2021)

N6-methyladenosine-methylomic landscape of lung tissues of mice with chronic obstructive pulmonary disease
por: Hu, Tingting, et al.
Publicado: (2023)

The Activation of M1 Macrophages is Associated with the JNK-m6A-p38 Axis in Chronic Obstructive Pulmonary Disease
por: Hu, Tingting, et al.
Publicado: (2023)

Immunosuppression by Inflammation-Stimulated Amplification of Myeloid-Derived Suppressor Cells and Changes in Expression of Immune Checkpoint HHLA2 in Chronic Obstructive Pulmonary Disease
por: Xu, Lijuan, et al.
Publicado: (2023)

Butyrate: Connecting the gut-lung axis to the management of pulmonary disorders
por: Corrêa, Renan Oliveira, et al.
Publicado: (2022)

Identification and Validation of Prognostic Markers for Lung Squamous Cell Carcinoma Associated with Chronic Obstructive Pulmonary Disease
por: Li, Zheng, et al.
Publicado: (2022)

A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome)
por: Zhen, Gao, et al.
Publicado: (2017)

Network pharmacology-based study to explore the mechanism of the Yiqi Gubiao pill in lung cancer treatment
por: Li, Zheng, et al.
Publicado: (2021)

Molecular and Clinicopathological Characteristics of Lung Cancer Concomitant Chronic Obstructive Pulmonary Disease (COPD)
por: Ma, Hongxia, et al.
Publicado: (2022)

COPD and Gut–Lung Axis: How Microbiota and Host Inflammasome Influence COPD and Related Therapeutics
por: Qu, Ling, et al.
Publicado: (2022)

Heterogeneity of ILC2s in the Lungs
por: Asaoka, Masato, et al.
Publicado: (2022)

Effect of Abnormal Savda Munziq, a Traditional Uighur Herbal Medicine, on Pulmonary Function and Aquaporins of COPD Rat Model with Abnormal Savda Syndrome
por: Zhen, Gao, et al.
Publicado: (2017)

Targeting Lung–Gut Axis for Regulating Pollution Particle–Mediated Inflammation and Metabolic Disorders
por: Cheng, Tzu-Yu, et al.
Publicado: (2023)

Solar ultraviolet B radiation promotes α-MSH secretion to attenuate the function of ILC2s via the pituitary–lung axis
por: Huang, Yuying, et al.
Publicado: (2023)

Effects of Modified Zhisou Powder on Airway Mucus Production in Chronic Obstructive Pulmonary Disease Model Rats with Cold-Dryness Syndrome
por: Zhen, Gao, et al.
Publicado: (2018)

Lung and Gut Microbiome in COPD
por: Karakasidis, Efstathios, et al.
Publicado: (2023)

Type 3 ILCs in Lung Disease
por: Ardain, Amanda, et al.
Publicado: (2019)

Traditional Chinese medicine classic herbal formula Xiaoqinglong decoction for acute exacerbation of chronic obstructive pulmonary disease: A systematic review protocol
por: Zhen, Gao, et al.
Publicado: (2018)

Nr4a1 marks a distinctive ILC2 activation subset in the mouse inflammatory lung
por: Xu, Shasha, et al.
Publicado: (2023)

The association between gut butyrate‐producing bacteria and non‐small‐cell lung cancer
por: Gui, Qifeng, et al.
Publicado: (2020)

Gut-derived butyrate suppresses ocular surface inflammation
por: Schaefer, Laura, et al.
Publicado: (2022)

Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation
por: Cavagnero, Kellen J., et al.
Publicado: (2021)

Effect of Hyssopus officinalis L. on inhibiting airway inflammation and immune regulation in a chronic asthmatic mouse model
por: MA, XIAOJUAN, et al.
Publicado: (2014)

Butyrate Attenuates Lung Inflammation by Negatively Modulating Th9 Cells
por: Vieira, Raquel de Souza, et al.
Publicado: (2019)

Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity
por: Han, Jihye, et al.
Publicado: (2022)

Coronavirus disease 2019 and the gut–lung axis
por: Zhou, Dan, et al.
Publicado: (2021)

Elevated plasma levels of pigment epithelium-derived factor correlated with inflammation and lung function in COPD patients
por: Li, Xiaoou, et al.
Publicado: (2015)

Functional changes of airway epithelial cells and mitochondria in rat models of asthenic lung and phlegm blocking combined with cough variant asthma
por: Liu, Huifang, et al.
Publicado: (2018)

ILC3, a Central Innate Immune Component of the Gut-Brain Axis in Multiple Sclerosis
por: Miljković, Đorđe, et al.
Publicado: (2021)

Selective deletion of SHIP-1 in hematopoietic cells in mice leads to severe lung inflammation involving ILC2 cells
por: Ye, Xujun, et al.
Publicado: (2021)

Role of ILC2 in Viral-Induced Lung Pathogenesis
por: Fonseca, Wendy, et al.
Publicado: (2021)

The gut-lung axis: Gut microbiota changes associated with pulmonary fibrosis in mouse models induced by bleomycin
por: Quan, Yunyun, et al.
Publicado: (2022)

Author Correction: Gut-derived butyrate suppresses ocular surface inflammation
por: Schaefer, Laura, et al.
Publicado: (2022)

Body Composition and COPD: A New Perspective
por: Wang, Xin, et al.
Publicado: (2023)

Gut-Lung Axis in COVID-19
por: Allali, Imane, et al.
Publicado: (2021)

The Gut-Lung Axis in Cystic Fibrosis
por: Price, Courtney E., et al.
Publicado: (2021)

Editorial: Gut-lung interaction axis
por: Pi, Jiang, et al.
Publicado: (2023)

A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis
por: Moretti, Silvia, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4593vr7vj61c5s6adkplmg9436